Visceral fat
Fat stored around the organs inside your abdomen. This is the type of fat tesamorelin has reduced in selected clinical studies.
Around organsTESAMORELIN · ABDOMINAL FAT & OBESITY
Visceral
Fat Burner.
If you’re managing obesity and carrying extra weight around your middle, understanding abdominal fat is a useful starting point. Explore tesamorelin’s role, what to track, and how to support your wider weight-loss goals.
The focus is deeper abdominal fat, preserving strength, and a sustainable plan.
01UNDERSTAND YOUR ABDOMINAL FAT
What’s behind
your waist size?
When your goal is a smaller waist, it helps to know that abdominal fat sits in two places: around the organs and beneath the skin. Both can contribute to the size of your abdomen.
Subcutaneous fat
Fat beneath the skin—the softer layer you can often pinch. Changes in this layer are a separate goal from reducing deeper visceral fat.
Under the skinTrack both your weight and your waist.
Record weight trends and measure your waist consistently. They tell you different things about your progress; a tape measure cannot isolate visceral fat. Use these alongside how your clothes fit, your strength, and your health checks.
WHAT THIS MEANS FOR ABDOMINAL OBESITY
A focus on deeper abdominal fat.
Tesamorelin’s area of interest is visceral fat. In a 12-month study of 60 adults with abdominal obesity and reduced growth-hormone release, it reduced this deeper fat compared with placebo. Fat beneath the abdominal skin did not change significantly.
For your overall plan, keep abdominal fat, appetite, and total body weight in view. The study involved a selected group and a different schedule from the example below, so its results cannot predict your response to that cycle.
02THE GROWTH-HORMONE PATHWAY
How tesamorelin
fits the picture.
Tesamorelin signals the body to release growth hormone, which influences fat metabolism. If hunger and portions are your main challenges, those need their own place in your obesity-care plan; tesamorelin does not work like a GLP-1 appetite treatment.
- 01
Tesamorelin
Activates GHRH receptors in the pituitary gland.
- 02
Growth hormone
Stimulates the body’s own growth-hormone release.
- 03
Metabolic effects
Raises IGF-1 and influences fat and tissue metabolism. Higher levels are not automatically better.
03STRENGTH DURING WEIGHT LOSS
Lose weight.
Keep strength in focus.
Keeping everyday tasks manageable matters alongside changes in your weight. Build your routine around regular movement, strength work, and nourishing meals.
MAKE THE PLAN FIT YOUR LIFEBuild from
Build from
your starting point.
You do not need an advanced gym routine to begin. Short activity sessions count. Work toward strength exercises on at least two days each week, using movements you can do safely.
Strength training helps support muscle during weight loss. In a trial of older adults with obesity, programs including resistance exercise limited lean-mass loss more than aerobic exercise alone.
Start where you are
Begin with manageable walks and strength exercises suited to your mobility. Build up gradually; the workout examples can be adapted to your starting point.
See workout examplesMake meals repeatable
Include protein, produce, and portions that support your calorie goal. Choose meals you can keep eating as part of everyday life.
Review food & macrosWatch the weekly trend
Compare weight and waist measurements over time. Also note practical changes, such as walking farther or finding daily tasks easier.
Estimate your calories04EXAMPLE COURSE & BREAKS
Twelve weeks on.
Four weeks off.
Example for clinical discussion
The example covers a 12-week course followed by a four-week break. During the course, the proposed dose is 2 mg per day, Sunday through Thursday, with Friday and Saturday off. This is a community-style example, not an established obesity-treatment schedule. The dose and suitability need a prescriber’s review.
PREFERRED TIMING IN THIS EXAMPLE
At night, before sleep
The example places scheduled doses at bedtime. Follow your prescriber’s timing instructions; research has not established bedtime as more effective.
12-week course
2 mg on Sunday–Thursday
Friday & Saturday off each week
4-week break
No tesamorelin during the break.
The weekly pattern during weeks 1–12
These weekly days off are separate from the full four-week break after week 12.
- Sunday2 mgProposed dose
- Monday2 mgProposed dose
- Tuesday2 mgProposed dose
- Wednesday2 mgProposed dose
- Thursday2 mgProposed dose
- FridayOffScheduled break
- SaturdayOffScheduled break
USE THE BREAK TO REVIEWPause the course.
Pause the course.
Review your progress.
The weekly days off and the four-week break serve different places in the example. Use the longer pause to review symptoms, waist and weight trends, IGF-1, and glucose with a clinician.
Keep nutrition and activity consistent. Visceral fat can return after treatment stops, so the longer-term plan matters beyond the course.
A break is not a proven receptor reset. Review your response before considering another course.
MAKE THE ROUTINE WORK FOR YOUA consistent plan.
A consistent plan.
A clearer picture.
Keep the weekly routine and your progress records simple enough to maintain.
One weekly rhythm
The example uses Sunday through Thursday during the course, with Friday and Saturday off. Keep the full four-week break separate from those weekly days off.
Track the whole picture
Log weight, waist, symptoms, food, activity, and other treatments. That context makes changes easier to interpret.
Review at week 12
Compare your results with the starting point. Use the review to decide what belongs in your continuing obesity-care plan.
05INDIVIDUAL CARE
Measure progress.
Monitor health.
Use weight and waist trends alongside blood sugar, symptoms, and follow-up. If you have prediabetes or diabetes, discuss glucose monitoring before considering tesamorelin.
What needs attention
- Glucose: assess before and during treatment; blood sugar can rise.
- IGF-1: monitor during treatment.
- Symptoms: report swelling, joint pain, numbness, or injection-site reactions.
- Response: review whether benefits justify continued treatment.
Do not use tesamorelin during pregnancy or breastfeeding. Contact the prescriber if planning pregnancy or if pregnancy occurs during treatment.
Build a plan you can keep using.
Use the main guide to estimate calories, plan satisfying meals, and choose movement that fits your current fitness and mobility.
Injection-site comfort
How and where to inject: the illustrated subcutaneous guide.
Itching, redness, or mild swelling can occur after injections. A clean, cool compress can help with mild local discomfort. Seek advice if symptoms persist.
Biofreeze Professional spray is for muscle and joint pain. Its label excludes wounded or irritated skin; it is not recommended here for injection-site itching.
Spreading redness, heat, worsening pain, or fever needs prompt assessment. Trouble breathing, facial swelling, or fainting requires emergency care.